ARHGAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.372200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.063400E-01
Normal-vs-Stage2
9.599400E-01
Normal-vs-Stage3
8.728200E-01
Normal-vs-Stage4
7.730600E-01
Stage1-vs-Stage2
1.555410E-01
Stage1-vs-Stage3
8.584800E-01
Stage1-vs-Stage4
1.365620E-01
Stage2-vs-Stage3
7.922600E-01
Stage2-vs-Stage4
7.440400E-01
Stage3-vs-Stage4
7.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.055200E-01
Normal-vs-AfricanAmerican
5.120600E-01
Normal-vs-Asian
9.859800E-01
Caucasian-vs-AfricanAmerican
3.831000E-01
Caucasian-vs-Asian
8.656800E-01
AfricanAmerican-vs-Asian
5.479600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.955400E-01
Normal-vs-Female
8.335000E-01
Male-vs-Female
4.194400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.347000E-01
Normal-vs-Age(41-60Yrs)
7.858000E-01
Normal-vs-Age(61-80Yrs)
8.417600E-01
Normal-vs-Age(81-100Yrs)
4.911400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.672200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.523400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.069400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.070360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.023150E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.323000E-01
Normal-vs-Daily Drinker
7.381800E-01
Normal-vs-Weekly Drinker
6.007400E-01
Normal-vs-Occasional Drinker
7.185600E-01
Normal-vs-Social Drinker
6.958200E-01
Non Drinker-vs-Daily Drinker
7.343600E-01
Non Drinker-vs-Weekly Drinker
5.610000E-02
Non Drinker-vs-Occasional Drinker
7.393800E-02
Non Drinker-vs-Social Drinker
1.130200E-01
Daily Drinker-vs-Weekly Drinker
1.118430E-01
Daily Drinker-vs-Occasional Drinker
1.893360E-01
Daily Drinker-vs-Social Drinker
2.019400E-01
Weekly Drinker-vs-Occasional Drinker
4.536000E-01
Weekly Drinker-vs-Social Drinker
5.725200E-01
Occasional Drinker-vs-Social Drinker
8.000000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.095700E-02
Normal-vs-Grade 2
9.564700E-03
Normal-vs-Grade 3
1.496220E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.280700E-03
Grade 1-vs-Grade 3
6.157200E-03
Grade 1-vs-Grade 4
7.095700E-02
Grade 2-vs-Grade 3
9.528800E-01
Grade 2-vs-Grade 4
9.564700E-03
Grade 3-vs-Grade 4
1.496220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.649400E-01
Normal-vs-NonDiabetic
9.854800E-01
Diabetic-vs-NonDiabetic
5.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.527000E-01
Normal-vs-NoPancreatitis
9.226200E-01
Pancreatitis-vs-NoPancreatitis
2.155200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.966400E-01
Normal-vs-N1
9.267800E-01
N0-vs-N1
9.546800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.715400E-01
Normal-vs-TP53-NonMutant
4.454000E-01
TP53-Mutant-vs-TP53-NonMutant
1.497420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
